Marginal efficacy of glucosamine: Comment on the article by Vlad et al and the editorial by Reginster [4]

Arthritis and Rheumatism

Volumn 58, Issue 1, 2008, Pages 332-

  Greenwald, Robert A ^a  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; CORTISONE; GLUCOSAMINE; HEPARIN; NONSTEROID ANTIINFLAMMATORY AGENT; WARFARIN;

ACUTE HEART INFARCTION; CLINICAL PRACTICE; DRUG EFFECT; DRUG EFFICACY; DRUG USE; EXPERIENCE; HUMAN; KNEE OSTEOARTHRITIS; LETTER; OUTCOME ASSESSMENT; PRIORITY JOURNAL;

CLINICAL TRIALS AS TOPIC; GLUCOSAMINE; HUMANS; META-ANALYSIS AS TOPIC; OSTEOARTHRITIS;

EID: 38149013996     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.23182     Document Type: Letter

References (2)

1. Vlad SC, LaValley MP, McAlindon TE, Felson DT. Glucosamine for pain in osteoarthritis: why do trial results differ? Arthritis Rheum 2007;56:2267-77.
2. Reginster JY. The efficacy of glucosamine sulfate in osteoarthritis: financial and nonfinancial conflict of interest [editorial]. Arthritis Rheum 2007;56:2105-10.